We previously reported that developmental A1254 exposure promotes dendritic growth in cerebellar Purkinje cells and cortical pyramidal neurons of weanling rats and that nanomolar concentrations of PCB-95 promote dendritic growth in cultured neocortical neurons (
Yang et al. 2009). Here, we extend these observations to show that
a) developmental exposure to the NDL PCB-95 in the maternal diet phenocopies the effect of developmental A1254 exposure on dendritic arborization in the developing hippocampus,
b) PCB-95 promotes dendritic growth in cultured hippocampal neurons at picomolar to nanomolar concentrations, and
c) the dendrite-promoting activity of PCB-95 requires RyR activity.
As a first test of the cause–effect relationship between PCB-enhanced RyR activity and PCB-induced dendritic growth, we compared dendritic growth in cultured hippocampal neurons exposed to PCB-95 vs. PCB-66. PCB-95 is a tri-
ortho substituted congener that potently sensitizes the RyR channel to physiological and pharmacological activators (
Wong and Pessah 1996) and preferentially stabilizes the RyR in its full open conformation (
Samso et al. 2009). PCB-66 has a single
ortho-chlorine substitution, and despite similar physicochemical properties to PCB-95, has negligible influence on RyR activity (
Pessah et al. 2006). In cultured hippocampal neurons, PCB-95 promotes dendritic growth, whereas PCB-66 has no effect at the concentrations tested. As a second test, blocking RyR function by either pharmacological antagonism or siRNA knockdown prevented PCB-95–induced dendritic growth. Interestingly, RyR1 siRNA and RyR2 siRNA were equally effective in blocking the dendrite-promoting activity of PCB-95. Studies in HEK cells confirmed that each siRNA was specific for its target mRNA and did not cross-react with non-target RyR mRNA. The native activities of both RyR isoforms are therefore required for the dendrite-promoting activity of PCB-95, and interference with either isoform is sufficient to prevent the influence of RyR-active PCBs, without altering basal dendritic growth or cell viability. The biology underlying the dual requirement for RyR1 and RyR2 in PCB-induced dendritic growth remains to be determined. We see three possible explanations.
One possibility is that each isoform regulates a complementary but distinct profile of downstream effectors necessary for dendritic growth. For example, both transcription- and translation-dependent pathways mediate activity-dependent dendritic growth (
Schratt et al. 2004;
Tsokas et al. 2005;
Vickers et al. 2005;
Wayman et al. 2008) and activity-dependent spine formation requires turning on signaling pathways that promote spine formation coincident with turning off signaling pathways that inhibit spine formation (
Impey et al. 2010;
Saneyoshi et al. 2010).
A second possibility is that activation of spatially segregated RyR1 and RyR2 channels creates Ca
2+ microdomains within the soma and the dendritic processes and terminals (
Berridge 2006) whose coincident activation is necessary for enhancing activity-dependent dendritic growth. As described in the companion paper (
Wayman et al. 2012), PCB-95 enhances spontaneous Ca
2+ oscillations within the soma and distal dendrites of the same neuron, and these effects are blocked by ryanodine. Collectively, these data indicate that NDL PCBs mediate the gain of RyR function that promotes dendritic growth, and they suggest a role for RyR in normal activity-dependent dendritic growth.
The human health relevance of these
in vitro mechanistic studies is supported by our observations that developmental PCB exposure similarly promotes dendritic growth in the developing brains of weanling rats. Using an exposure paradigm relevant to human PCB exposures in terms of route of exposure, dose level, and dose duration (
Yang et al. 2009), we observed that A1254 increases dendritic growth in pyramidal neurons of the CA1 hippocampus. A1254 is composed predominantly of NDL PCB congeners with RyR activity (
Kostyniak et al. 2005), consistent with our
in vitro data establishing that PCBs promote dendritic growth via RyR-dependent mechanisms. The proposal that NDL PCBs contribute to the dendrite-promoting activity of A1254 is strengthened by the observation that developmental exposure to PCB-95 in the maternal diet similarly stimulates dendritic growth
in vivo. Interestingly, over the dose ranges tested in this study, PCB-95, but not A1254, exhibited an inverted dose–response relationship. Although we cannot rule out the possibility that nonlinearity would also be observed with A1254 at doses > 6 mg/kg/day, the different dose–response relationships observed for A1254 vs. PCB-95 may reflect the fact that A1254 is a mixture of DL and NDL PCBs with varying RyR potency (
Kostyniak et al. 2005). Alternatively, up-regulation of cytochrome P450 enzymes by DL PCBs in A1254 could result in different toxicokinetics of NDL PCBs in A1254- vs. PCB-95–exposed animals (
Gauger et al. 2007;
Giera et al. 2011).
The nonlinear dose response of developmental PCB-95 exposure on dendritic growth
in vivo is recapitulated
in vitro. The loss of dendrite-promoting activity
in vitro at PCB-95 concentrations > 2 μM is likely not due to decreased cell viability (
Howard et al. 2003). A plausible explanation is that chronic RyR sensitization alters RyR expression and/or activity, in an inverted concentration-related manner, which is perhaps due to local production of reactive oxygen species (ROS) by PCBs (
Fonnum et al. 2006). Microsomal RyR complexes possess a small number of highly reactive cysteines that confer tight regulation of Ca
2+ channel activity in response to changing transmembrane redox potential (
Feng et al. 2000;
Liu et al. 1994). Thus the sensitizing and desensitizing influence of RyR-active PCBs on Ca
2+ signaling may be strongly influenced by the level of ROS production (
Pessah et al. 2002). A parallel mechanism has been demonstrated in which moderate increases in Ca
2+ promote dendritic growth, whereas large increases cause dendritic retraction (
Lohmann and Wong 2005;
Segal et al. 2000). Thus, when increasing the concentration of PCB-95 from 200 nM to 2 μM, intracellular Ca
2+ concentrations may cross the threshold from concentrations that promote dendritic growth to those that cause dendritic retraction.
A third possibility is suggested by the report that transfection of cortical neurons with constitutively active CaMKIV (Ca
2+/calmodulin-dependent protein kinase IV) promotes dendritic growth, whereas expression of constitutively active CaMKII (Ca
2+/calmodulin-dependent protein kinase II) inhibits dendritic growth (
Redmond et al. 2002). Perhaps at higher concentrations that do not promote dendritic growth, PCBs are preferentially activating Ca
2+-dependent signaling molecules that inhibit dendritic growth. Distinguishing between these possibilities is the focus of future studies.
These data linking a direct molecular effect of NDL PCBs (sensitized RyR activity) to disruption of a specific neurodevelopmental event (dendritic arborization) have significant implications for understanding how PCBs interfere with normal neurodevelopment in the human brain. Structural aberrations in the dendritic arbors of central neurons are thought to contribute to clinical manifestations of diverse heritable and environmentally induced neurodevelopmental disorders in humans (
Bourgeron 2009;
Fukuda et al. 2005;
Garey 2010;
Penzes et al. 2011;
Svitkina et al. 2010). Consistent with this, developmental A1254 exposure altered dendritic arborization in weanling rats coincident with performance deficits in the Morris swim task (
Yang et al. 2009) and exposure to PCB-95 on gestation days 10–16 altered behavior in adult rats (
Schantz et al. 1997). NDL PCB congeners with the highest activity towards RyRs, including PCB-95, collectively represent 40–50% of the total PCBs currently found in environmental and biotic samples, and their net effects are likely to be additive (
Pessah et al. 2006). However, even low levels of PCB exposure might adversely influence neuronal connectivity in the developing brain of genetically susceptible individuals. Mutations in
RYR (ryanodine receptor) genes have been linked to environmentally triggered disorders in humans including malignant hyperthermia (
Pessah et al. 1996), cardiac arrhythmias (
Wehrens et al. 2005), and sudden death (
Laitinen et al. 2004). Recent studies demonstrate that specific
RYR mutations confer sex– and gene–dose-dependent susceptibility to pharmacological (halogenated anesthetic) and environmental (heat) stressors that trigger malignant hyperthermia and muscle damage in otherwise asymptomatic individuals (
Barrientos et al. 2012;
Yuen et al. 2012). Importantly, PCB-95 is significantly more potent and efficacious in disrupting cation regulation of mutant R615C-
RYR1 compared with wild type RyR1 (
Ta and Pessah 2007). Considered together, these observations identify PCBs, and in particular NDL PCBs with high RyR activity, as candidate environmental risk factors in neurodevelopmental disorders and provide important new clues about the possible role of RyRs in contributing to heritable and environmentally triggered neurodevelopmental deficits.